Safeguarding Australia's healthcare sector with a new nuclear medicine facility
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
Showing 241 - 260 of 1181 results
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
ANSTO and the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) have been recognised for their valuable contributions to the search and recovery efforts for a missing 8mm-long radioactive capsule in the Western Australian outback.
ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.
The Japanese experience with leading-edge radiation treatment for cancer shows tremndous success
An international team led by scientists at City University of Hong Kong has found flexible metal-organic framework (MOF) with one-dimensional channels that acts as a “molecular trapdoor” to selectively adsorb gases, such as carbon dioxide, in response to temperature and pressure changes.
Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.
Lithium Australia, a company that has a close association with ANSTO’s business unit Minerals, has been awarded a US patent for its unique lithium mining technology SiLeach®.
Detailed data on ANSTO electricity use and CO2 emissions for FY2022 - FY2023
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
With over 70 years of nuclear expertise, ANSTO offers expert education and training programs
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.
ANSTO has a full suite of mineralogical, chemical and hydrometallurgical facilities from laboratory through to pilot scale.
Australia’s new Mo-99 manufacturing facility reaches practical completion
Research will change understanding of Australian Aboriginal rock art found in rock shelters of the Kimberley and its relationship to a changing landscape